132 related articles for article (PubMed ID: 32191180)
21. A review of ECG and QT interval measurement use in a public psychiatric inpatient setting.
Berling I; Gupta R; Bjorksten C; Prior F; Whyte IM; Berry S
Australas Psychiatry; 2018 Feb; 26(1):50-55. PubMed ID: 28836822
[TBL] [Abstract][Full Text] [Related]
22. QT interval variability and adaptation to heart rate changes in patients with long QT syndrome.
Nemec J; Buncová M; Shusterman V; Winter B; Shen WK; Ackerman MJ
Pacing Clin Electrophysiol; 2009 Jan; 32(1):72-81. PubMed ID: 19140916
[TBL] [Abstract][Full Text] [Related]
23. QT interval measurement: evaluation of automatic QTc measurement and new simple method to calculate and interpret corrected QT interval.
Charbit B; Samain E; Merckx P; Funck-Brentano C
Anesthesiology; 2006 Feb; 104(2):255-60. PubMed ID: 16436843
[TBL] [Abstract][Full Text] [Related]
24. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
[TBL] [Abstract][Full Text] [Related]
25. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
Isbister GK; Balit CR; Macleod D; Duffull SB
J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
[TBL] [Abstract][Full Text] [Related]
26. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
Batey AJ; Doe CP
J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men.
Dogan A; Tunc E; Varol E; Ozaydin M; Ozturk M
Ann Noninvasive Electrocardiol; 2005 Apr; 10(2):134-41. PubMed ID: 15842424
[TBL] [Abstract][Full Text] [Related]
28. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
29. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
[TBL] [Abstract][Full Text] [Related]
30. QT Corrections for Long QT Risk Assessment: Implications for the Preparticipation Examination.
Hadley D; Hsu D; Pickham D; Drezner JA; Froelicher VF
Clin J Sport Med; 2019 Jul; 29(4):285-291. PubMed ID: 31241530
[TBL] [Abstract][Full Text] [Related]
31. Clinical assessment of drug-induced QT prolongation in association with heart rate changes.
Extramiana F; Maison-Blanche P; Cabanis MJ; Ortemann-Renon C; Beaufils P; Leenhardt A
Clin Pharmacol Ther; 2005 Apr; 77(4):247-58. PubMed ID: 15903123
[TBL] [Abstract][Full Text] [Related]
32. Exponential correction of QT interval to minimize the effect of the heart rate in children.
Yoshinaga M; Tomari T; Aihoshi S; Kawashita T; Nishi J; Tanaka Y; Takezaki T; Kono Y; Yuasa Y; Nakamura M
Jpn Circ J; 1993 Feb; 57(2):102-8. PubMed ID: 8450593
[TBL] [Abstract][Full Text] [Related]
33. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
34. Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
Kawabata M; Hirao K; Takeshi S; Sakurai K; Inagaki H; Hachiya H; Isobe M
J Electrocardiol; 2008; 41(2):117-22. PubMed ID: 18328336
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and Outcome of High-Risk QT Prolongation Recorded in the Emergency Department from an Institution-Wide QT Alert System.
Anderson HN; Bos JM; Haugaa KH; Morlan BW; Tarrell RF; Caraballo PJ; Ackerman MJ
J Emerg Med; 2018 Jan; 54(1):8-15. PubMed ID: 29107482
[TBL] [Abstract][Full Text] [Related]
36. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
Kirchhof P; Franz MR; Bardai A; Wilde AM
J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
[TBL] [Abstract][Full Text] [Related]
37. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval.
Indik JH; Pearson EC; Fried K; Woosley RL
Heart Rhythm; 2006 Sep; 3(9):1003-7. PubMed ID: 16945790
[TBL] [Abstract][Full Text] [Related]
38. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
39. Calculation of QT shift in non clinical safety pharmacology studies.
Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
[TBL] [Abstract][Full Text] [Related]
40. Electrocardiographic biomarkers of ventricular repolarisation in a single family of short QT syndrome and the role of the Bazett correction formula.
Extramiana F; Maury P; Maison-Blanche P; Duparc A; Delay M; Leenhardt A
Am J Cardiol; 2008 Mar; 101(6):855-60. PubMed ID: 18328853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
